FSH treatment of male idiopathic infertility improves pregnancy rate: A meta-analysis

Endocrine Connections

Volumn 4, Issue 3, 2015, Pages R46-R58

  Santi, D ^a,b   Granata, A R M ^b   Simoni, M ^a,b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b AUSL Modena   (Italy)

Author keywords

FSH; Infertile couples; Male infertility

Indexed keywords

FOLLITROPIN; GONADOTROPIN; PLACEBO;

ARTICLE; CLINICAL DECISION MAKING; CONTROLLED CLINICAL TRIAL (TOPIC); DEMOGRAPHY; ECHOGRAPHY; HUMAN; IDIOPATHIC DISEASE; INFERTILITY THERAPY; MALE GENITAL TRACT PARAMETERS; MALE INFERTILITY; META ANALYSIS; OLIGOSPERMIA; PREGNANCY RATE; PRIORITY JOURNAL; SEMEN ABNORMALITY; SPERM QUALITY; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY; TESTICULAR VOLUME;

EID: 84973335916     PISSN: None     EISSN: 20493614     Source Type: Journal    
DOI: 10.1530/EC-15-0050     Document Type: Article

References (54)

1. Isaksson R & Tiitinen A. Present concept of unexplained infertility. Gynecological Endocrinology 2004 18 278-290. (doi:10.1080/ 0951359042000199878)
2. de Kretser DM. Male infertility. Lancet 1997 349 787-790. (doi:10.1016/ S0140-6736(96)08341-9)
3. Wang C & Swerdloff RS. Limitations of semen analysis as a test of male fertility and anticipated needs from newer tests. Fertility and Sterility 2014 102 1502-1507. (doi:10.1016/j.fertnstert.2014.10.021)
4. Leifke E & Nieschlag E. Male infertility treatment in the light of evidence-based medicine. Andrologia 1996 28 (Suppl 1) 23-30.
5. Jung JH & Seo JT. Empirical medical therapy in idiopathic male infertility: promise or panacea? Clinical and Experimental Reproductive Medicine 2014 41 108-114. (doi:10.5653/cerm.2014.41.3.108)
6. Rittenberg V & El-Toukhy T. Medical treatment of male infertility. Human Fertility 2010 13 208-216. (doi:10.3109/14647273.2010. 534833)
7. Edwards RG. Maturation in vitro of human ovarian oocytes. Lancet 1965 2 926-929. (doi:10.1016/S0140-6736(65)92903-X)
8. Nyboe Andersen A, Carlsen E & Loft A. Trends in the use of intracytoplasmatic sperm injection marked variability between countries. Human Reproduction Update 2008 14 593-604. (doi:10.1093/ humupd/dmn032)
9. Baccetti B, Strehler E, Capitani S, Collodel G, De Santo M, Moretti E, Piomboni P, Wiedeman R & Sterzik K. The effect of follicle stimulating hormone therapy on human spermstructure (Notulae seminologicae 11). Human Reproduction 1997 12 1955-1968. (doi:10.1093/humrep/12. 9.1955)
10. Acosta AA, Khalifa E & Oehninger S. Pure human follicle stimulating hormone has a role in the treatment of severe male infertility by assisted reproduction: Norfolk's total experience. Human Reproduction 1992 7 1067-1072.
11. Acosta AA, Oehninger S, Ertunc H & Philput C. Possible role of pure human follicle-stimulating hormone in the treatment of severe malefactor infertility by assisted reproduction: preliminary report. Fertility and Sterility 1991 55 1150-1156.
12. Ashkenazi J, Bar-Hava I, Farhi J, Levy T, Feldberg D, Orvieto R & Ben-Rafael Z. The role of purified follicle stimulating hormone therapy in the male partner before intracytoplasmic sperm injection. Fertility and Sterility 1999 72 670-673. (doi:10.1016/S0015-0282(99)00322-2)
13. Kamischke A, Behre HM, Bergmann M, Simoni M, Schafer T & Nieschlag E. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled, clinical trial. Human Reproduction 1998 13 596-603. (doi:10.1093/humrep/13.3.596)
14. Baccetti B, Piomboni P, Bruni E, Capitani S, Gambera L, Moretti E, Sterzik K & Strehler E. Effect of follicle-stimulating hormone on sperm quality and pregnancy rate. Asian Journal of Andrology 2004 6 133-137.
15. Attia AM, Abou-Setta AM & Al-Inany HG. Gonadotrophins for idiopathic male factor subfertility. Cochrane Database of Systematic Reviews 2013 8 CD005071. (doi:10.1002/14651858.CD005071.pub2)
16. Paradisi R, Busacchi P, Seracchioli R, Porcu E & Venturoli S. Effects of high doses of recombinant human follicle-stimulating hormone in the treatment of male factor infertility: results of a pilot study. Fertility and Sterility 2006 86 728-731. (doi:10.1016/j.fertnstert.2006.02.087)
17. Moher D, Altman DG, Liberati A & Tetzlaff J. PRISMA statement. Epidemiology 2011 22 128. (doi:10.1097/EDE.0b013e3181fe7825)
18. Moher D, Liberati A, Tetzlaff J & Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. International Journal of Surgery 2010 8 336-341. (doi:10.1016/j.ijsu.2010. 02.007)
19. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ & McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials 1996 17 1-12. (doi:10.1016/0197-2456(95)00134-4)
20. Chandler J, Clarke M & Higgins J. The Cochrane Collaboration. Cochrane Methods. Eds J Chandler, M Clarke & J Higgins. UK: John Wiley & Sons Ltd, 2012.
21. Easterbrook PJ, Berlin JA, Gopalan R & Matthews DR. Publication bias in clinical research. Lancet 1991 337 867-872. (doi:10.1016/0140- 6736(91)90201-Y)
22. Egger M, Davey Smith G, Schneider M & Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997 315 629-634. (doi:10.1136/bmj.315.7109.629)
23. Berker B, Kahraman K, Taskin S, Sukur YE, Sonmezer M & Atabekoglu CS. Recombinant FSH versus clomiphene citrate for ovarian stimulation in couples with unexplained infertility and male subfertility undergoing intrauterine insemination: a randomized trial. Archives of Gynecology and Obstetrics 2011 284 1561-1566. (doi:10.1007/ s00404-011-1997-4)
24. Dwyer AA, Sykiotis GP, Hayes FJ, Boepple PA, Lee H, Loughlin KR, Dym M, Sluss PM, Crowley WF Jr & Pitteloud N. Trial of recombinant follicle-stimulating hormone pretreatment for GnRH-induced fertility in patients with congenital hypogonadotropic hypogonadism. Journal of Clinical Endocrinology and Metabolism 2013 98 E1790-E1795. (doi:10.1210/jc.2013-2518)
25. Goldman MB, Thornton KL, Ryley D, Alper MM, Fung JL, Hornstein MD & Reindollar RH. A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T). Fertility and Sterility 2014 101 1574-1581.e1-2. (doi:10.1016/j.fertnstert.2014.03.012)
26. Hussein A, Ozgok Y, Ross L, Rao P & Niederberger C. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study. BJU International 2013 111 E110-E114. (doi:10.1111/j.1464-410X.2012. 11485.x)
27. Sagnella F, Moro F, Lanzone A, Tropea A, Martinez D, Capalbo A, Gangale MF, Spadoni V, Morciano A&Apa R. A prospective randomized noninferiority study comparing recombinant FSH and highly purified menotropin in intrauterine insemination cycles in couples with unexplained infertility and/or mild-moderate male factor. Fertility and Sterility 2011 95 689-694. (doi:10.1016/j.fertnstert.2010.08.044)
28. Selman H, De Santo M, Sterzik K, Cipollone G, Aragona C & El-Danasouri I. Rescue of spermatogenesis arrest in azoospermic men after long-term gonadotropin treatment. Fertility and Sterility 2006 86 466-468. (doi:10.1016/j.fertnstert.2005.12.055)
29. Strehler E, Capitani S, Collodel G, De Santo M, Moretti E, Piomboni P, Sterzik S & Baccetti B. Submicroscopic mathematical evaluation of spermatozoa in assisted reproduction. I. Intracytoplasmic sperm injection. (Notulae seminologicae 6). Journal of Submicroscopic Cytology and Pathology 1995 27 573-586.
30. Bouloux P, Warne DW & Loumaye E. Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertility and Sterility 2002 77 270-273. (doi:10.1016/S0015-0282(01)02973-9)
31. Efesoy O, Cayan S & Akbay E. The efficacy of recombinant human follicle-stimulating hormone in the treatment of various types of male-factor infertility at a single university hospital. Journal of Andrology 2009 30 679-684. (doi:10.2164/jandrol.108.007278)
32. Liu PY, Turner L, Rushford D, McDonald J, Baker HW, Conway AJ & Handelsman DJ. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men. Human Reproduction 1999 14 1540-1545. (doi:10.1093/humrep/14.6.1540)
33. Merino G, Carranza-Lira S, Martinez-Chequer JC, Barahona E, Moran C & Bermudez JA. Sperm characteristics and hormonal profile before and after treatment with follicle-stimulating hormone in infertile patients. Archives of Andrology 1996 37 197-200. (doi:10.3109/ 01485019608988522)
34. Glander HJ & Kratzsch J. Effects of pure human follicle-stimulating hormone (pFSH) on sperm quality correlate with the hypophyseal response to gonadotrophin-releasing hormone (GnRH). Andrologia 1997 29 23-28. (doi:10.1111/j.1439-0272.1997.tb03144.x)
35. Bartoov B, Eltes F, Lunenfeld E, Har-Even D, Lederman H & Lunenfeld B. Sperm quality of subfertile males before and after treatment with human follicle-stimulating hormone. Fertility and Sterility 1994 61 727-734.
36. Ben-Rafael Z, Farhi J, Feldberg D, Bartoov B, Kovo M, Eltes F & Ashkenazi J. Follicle-stimulating hormone treatment for men with idiopathic oligoteratoasthenozoospermia before in vitro fertilization: the impact on sperm microstructure and fertilization potential. Fertility and Sterility 2000 73 24-30. (doi:10.1016/S0015-0282(99)00461-6)
37. Caroppo E, Niederberger C, Vizziello GM & D'Amato G. Recombinant human follicle-stimulating hormone as a pretreatment for idiopathic oligoasthenoteratozoospermic patients undergoing intracytoplasmic sperm injection. Fertility and Sterility 2003 80 1398-1403. (doi:10.1016/ S0015-0282(03)02202-7)
38. Colacurci N, Monti MG, Fornaro F, Izzo G, Izzo P, Trotta C, Mele D & De Franciscis P. Recombinant human FSH reduces sperm DNA fragmentation in men with idiopathic oligoasthenoteratozoospermia. Journal of Andrology 2012 33 588-593. (doi:10.2164/jandrol.111. 013326)
39. Foresta C, Bettella A, Garolla A, Ambrosini G & Ferlin A. Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study. Fertility and Sterility 2005 84 654-661. (doi:10.1016/j.fertnstert.2005.03.055)
40. Foresta C, Bettella A, Merico M, Garolla A, Ferlin A & Rossato M. Use of recombinant human follicle-stimulating hormone in the treatment of male factor infertility. Fertility and Sterility 2002 77 238-244. (doi:10.1016/S0015-0282(01)02966-1)
41. Foresta C, Bettella A, Merico M, Garolla A, Plebani M, Ferlin A & Rossato M. FSH in the treatment of oligozoospermia. Molecular and Cellular Endocrinology 2000 161 89-97. (doi:10.1016/S0303- 7207(99)00228-2)
42. Foresta C, Selice R, Moretti A, Pati MA, Carraro M, Engl B & Garolla A. Gonadotropin administration after gonadotropin-releasing-hormone agonist: a therapeutic option in severe testiculopathies. Fertility and Sterility 2009 92 1326-1332. (doi:10.1016/j.fertnstert.2008.07.1766)
43. Knuth UA, Honigl W, Bals-Pratsch M, Schleicher G & Nieschlag E. Treatment of severe oligospermia with human chorionic gonadotropin/ human menopausal gonadotropin: a placebo-controlled, double blind trial. Journal of Clinical Endocrinology and Metabolism 1987 65 1081-1087. (doi:10.1210/jcem-65-6-1081)
44. Matorras R, Perez C, Corcostegui B, Pijoan JI, Ramon O, Delgado P & Rodriguez-Escudero FJ. Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband's spermatozoa: a randomized study. Human Reproduction 1997 12 24-28. (doi:10.1093/ humrep/12.1.24)
45. Selice R, Garolla A, Pengo M, Caretta N, Ferlin A & Foresta C. The response to FSH treatment in oligozoospermic men depends on FSH receptor gene polymorphisms. International Journal of Andrology 2011 34 306-312. (doi:10.1111/j.1365-2605.2010.01086.x)
46. van Wely M, Kwan I, Burt AL, Thomas J, Vail A, Van der Veen F & Al-Inany HG. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles. A Cochrane review. Human Reproduction Update 2012 18 111. (doi:10.1093/ humupd/dmr048)
47. Baker K, Li J & Sabanegh E Jr. Analysis of semen parameters in male referrals: impact of reference limits, stratification by fertility categories, predictors of change, and comparison of normal semen parameters in subfertile couples. Fertility and Sterility 2015 103 59-65.e5. (doi:10.1016/j.fertnstert.2014.09.043)
48. World Health Organization, Department of Reproductive Health and Research. WHO Laboratory Manual for the Examination and Processing of Human Semen, 5th edn. Ed TG Cooper. Geneva, Switzerland: WHO, 2010. (available at: http://whqlibdoc.who.int/publications/2010/ 9789241547789_eng.pdf)
49. Baccetti B, Bernieri G, Burrini AG, Collodel G, Crisa N, Mirolli M, Moretti E & Piomboni P. Notulae seminologicae. 5. Mathematical evaluation of interdependent submicroscopic sperm alterations. Journal of Andrology 1995 16 356-371.
50. van Alphen MM, van de Kant HJ & de Rooij DG. Follicle-stimulating hormone stimulates spermatogenesis in the adult monkey. Endocrinology 1988 123 1449-1455. (doi:10.1210/endo-123-3-1449)
51. Heseltine D, White MC, Kendall-Taylor P, De Kretser DM & Kelly W. Testicular enlargement and elevated serum inhibin concentrations occur in patients with pituitary macroadenomas secreting follicle stimulating hormone. Clinical Endocrinology 1989 31 411-423. (doi:10.1111/j.1365-2265.1989.tb01265.x)
52. Lotti F & Maggi M. Ultrasound of the male genital tract in relation to male reproductive health. Human Reproduction Update 2015 21 56-83. (doi:10.1093/humupd/dmu042)
53. Behre HM, Nashan D & Nieschlag E. Objective measurement of testicular volume by ultrasonography: evaluation of the technique and comparison with orchidometer estimates. International Journal of Andrology 1989 12 395-403. (doi:10.1111/j.1365-2605.1989. tb01328.x)
54. Simoni M & Casarini L. Potential for pharmacogenetic use of FSH: a 2014-and-beyond view. European Journal of Endocrinology 2013 170 R91-R107. (doi:10.1530/EJE-13-0624)